Author:
Swigris Jeffrey J.,Fairclough Diane
Funder
National Institutes of Health
Subject
Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Assessing health-related quality of life in patients with interstitial lung diseases;BMC Pulmonary Medicine;2024-09-13
2. Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on ‘Feels, Functions, Survives’. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency;American Journal of Respiratory and Critical Care Medicine;2024-03-15
3. Pulmonary Fibrosis Stakeholder Summit: A Joint National Heart, Lung, and Blood Institute, Three Lakes Foundation, and Pulmonary Fibrosis Foundation Workshop Report;American Journal of Respiratory and Critical Care Medicine;2023-12-19
4. Dyspnea Associates With a Widely Impaired Quality of Life in Idiopathic Pulmonary Fibrosis Patients: A Longitudinal Study Using 15D;Journal of Palliative Medicine;2023-10-01
5. PROMising developments in IPF patient-reported outcome measures;European Respiratory Journal;2022-01